Clinical Trial Update: Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bupivacaine for postoperative pain after impacted third molar extraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Teeth Impacted

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: CES University | Conditions: Teeth, Impacted | Phase 4 | Status: COMPLETED